Home › Obesity in Children › NCT06870578
Building Research for Intervention Development in Gliosis and Eating Habits
RecruitingHealthy volunteers welcome
Fostering Patient-oriented Research in Cardiometabolic Disease Pathogenesis and Prevention
Who can join
Ages 9 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Study1: Adult caregiver and Child age 9-11y. Willing to come to in-person focus group * Study 2: Age 9-11y, BMI ≥85th and ≤95th percentile for age and sex * Study 3:Adult caregiver with child who qualify for free or reduced-cost lunch in WA State. Child age 9-11y and with overweight. Exclusion Criteria (study 1 child participants and study 3 criteria for children of adult participants): * Significant health conditions including type 2 diabetes * History of major weight loss or eating disorder * Current use of medications known to alter appetite or body weight (e.g., stimulants for ADHD) * Documented cognitive disorder * Severe food allergies, vegetarian, or vegan (Study 1 only) * Unable to make the session date Exclusion Criteria (study 2, child participants): * Significant health conditions including type 2 diabetes * History of major weight loss or eating disorder * Current use of medications known to alter appetite or body weight (e.g., stimulants for ADHD) * Documented cognitive disorder * MRI contraindication (e.g., braces, claustrophobia) * Weight \>330 pounds (MRI limit) * Severe food allergies, vegetarian, or vegan * Currently in formal weight loss program
About the study
The goal of this study is to 1) use magnetic resonance imaging (MRI) to evaluate the effect of nutritious foods on inflammation in the human hypothalamus of children and 2) assess the feasibility and acceptability of nutritious food feeding intervention strategies in children with overweight or obesity.
What is being tested
- Diet modification (other)
Sponsor: University of Washington · Participants: 75 · Started: Apr 3, 2025
Contact the study team
- BRIDGE Study · Phone: 206 616-6360
Official record on ClinicalTrials.gov — NCT06870578
Locations in the U.S.
| Washington | University of Washington, Seattle |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.